Persistent truncus arteriosus secondary prevention

Revision as of 03:06, 16 April 2020 by Fahimeh Shojaei (talk | contribs) (Created page with "__NOTOC__ {{Persistent truncus arteriosus}} {{CMG}}; {{AE}} {{Fs}} ==Overview== There are no established measures for the secondary prevention of [disease name]. OR Effecti...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Persistent truncus arteriosus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Persistent truncus arteriosus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Persistent truncus arteriosus secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Persistent truncus arteriosus secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Persistent truncus arteriosus secondary prevention

CDC on Persistent truncus arteriosus secondary prevention

Persistent truncus arteriosus secondary prevention in the news

Blogs on Persistent truncus arteriosus secondary prevention

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Persistent truncus arteriosus secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].

Secondary Prevention

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include:

  • [Strategy 1]
  • [Strategy 2]
  • [Strategy 3]

References

Template:WH Template:WS